Tapewire

NYSE · USD

CC

Chemours Co

Export transactions ↓
Tapewire entity
4420
SEC CIK
0001627223
Parsed reports
500

Last 12 months

Inside the activity.

7 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202670
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2023 Filed Mar 4, 2023 02:04 UTC
Dignam DenisePresident, Adv Perf Materials
GrantStock Option (Right to Buy) · Derivative 13,427 $0.00 Strike: $34.84 $0.00
Disclosure

SEC source: 0001209191-23-016095 · doc4.xml · derivative · entry 5

Dignam Denise · CIK 0001848475 · President, Adv Perf Materials

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,427

Underlying: Common Stock · 13,427 shares

Expires 2033-03-01

F5 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:04 UTC
Dignam DenisePresident, Adv Perf Materials
GrantCommon Stock 14,351 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016095 · doc4.xml · nonDerivative · entry 3

Dignam Denise · CIK 0001848475 · President, Adv Perf Materials

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,785.4596

F4 · shares: Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on March 1, 2026.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:04 UTC
Dignam DenisePresident, Adv Perf Materials
GrantCommon Stock 5,919 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016095 · doc4.xml · nonDerivative · entry 2

Dignam Denise · CIK 0001848475 · President, Adv Perf Materials

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,434.4596

F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:04 UTC
Dignam DenisePresident, Adv Perf Materials
Tax withholdingCommon Stock 522 $34.84 $18,186.48
Disclosure

SEC source: 0001209191-23-016095 · doc4.xml · nonDerivative · entry 1

Dignam Denise · CIK 0001848475 · President, Adv Perf Materials

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,515.4596

F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:01 UTC
Bellezza AlishaPresident, Thermal Spec Solns
GrantPerformance Stock Option (Right to Buy) · Derivative 13,238 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-016094 · doc4.xml · derivative · entry 5

Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,238

Underlying: Common Stock · 13,238 shares

Expires 2033-03-01

F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:01 UTC
Bellezza AlishaPresident, Thermal Spec Solns
GrantStock Option (Right to Buy) · Derivative 13,427 $0.00 Strike: $34.84 $0.00
Disclosure

SEC source: 0001209191-23-016094 · doc4.xml · derivative · entry 4

Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,427

Underlying: Common Stock · 13,427 shares

Expires 2033-03-01

F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:01 UTC
Bellezza AlishaPresident, Thermal Spec Solns
GrantCommon Stock 5,919 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016094 · doc4.xml · nonDerivative · entry 2

Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,873.857

F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 02:01 UTC
Bellezza AlishaPresident, Thermal Spec Solns
Tax withholdingCommon Stock 525 $34.84 $18,291.00
Disclosure

SEC source: 0001209191-23-016094 · doc4.xml · nonDerivative · entry 1

Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,954.857

F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:49 UTC
Scarborough AlveniaSVP Corp Communications & CBO
GrantPerformance Stock Options (Right to Buy) · Derivative 5,215 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-016083 · doc4.xml · derivative · entry 5

Scarborough Alvenia · CIK 0001826993 · SVP Corp Communications & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,215

Underlying: Common Stock · 5,215 shares

Expires 2033-03-01

F5 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:49 UTC
Scarborough AlveniaSVP Corp Communications & CBO
GrantStock Options (Right to Buy) · Derivative 5,289 $0.00 Strike: $34.84 $0.00
Disclosure

SEC source: 0001209191-23-016083 · doc4.xml · derivative · entry 4

Scarborough Alvenia · CIK 0001826993 · SVP Corp Communications & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,289

Underlying: Common Stock · 5,289 shares

Expires 2033-03-01

F4 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:49 UTC
Scarborough AlveniaSVP Corp Communications & CBO
GrantCommon Stock 2,332 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-016083 · doc4.xml · nonDerivative · entry 2

Scarborough Alvenia · CIK 0001826993 · SVP Corp Communications & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,432.673

F3 · shares: Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2024.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 4, 2023 01:49 UTC
Scarborough AlveniaSVP Corp Communications & CBO
Tax withholdingCommon Stock 300 $34.84 $10,452.00
Disclosure

SEC source: 0001209191-23-016083 · doc4.xml · nonDerivative · entry 1

Scarborough Alvenia · CIK 0001826993 · SVP Corp Communications & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,100.673

F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 13:53 UTC Amendment
Wisel CamelaVP, CAO & Controller
GrantPerformance Stock Option (Right to Buy) · Derivative 5,010 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017762 · doc4a.xml · derivative · entry 1

Wisel Camela · CIK 0001886003 · VP, CAO & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,010

Underlying: Common Stock · 5,010 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 13:42 UTC Amendment
Sparks Edwin CPresident, Titan Tech Chem Sol
GrantPerformance Stock Option (Right to Buy) · Derivative 18,370 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017757 · doc4a.xml · derivative · entry 1

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,370

Underlying: Common Stock · 18,370 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 13:56 UTC Amendment
Newman MarkDirector · President and CEO
GrantPerformance Stock Option (Right to Buy) · Derivative 100,200 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017763 · doc4a.xml · derivative · entry 1

Newman Mark · CIK 0001524597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,200

Underlying: Common Stock · 100,200 shares

Expires 2023-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 13:38 UTC Amendment
Kelliher Susan M.SVP, People and Health Service
GrantPerformance Option (Right to Buy) · Derivative 11,690 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017755 · doc4a.xml · derivative · entry 1

Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,690

Underlying: Common Stock · 11,690 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 18:51 UTC Amendment
Wellman Kristine MSVP, GC & Corp. Secretary
GrantPerformance Stock Option (Right to Buy) · Derivative 10,855 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017761 · doc4a.xml · derivative · entry 1

Wellman Kristine M · CIK 0001948665 · SVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,855

Underlying: Common Stock · 10,855 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 18:50 UTC Amendment GrantPerformance Stock Option (Right to Buy) · Derivative 28,807 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017759 · doc4a.xml · derivative · entry 1

Ralhan Sameer · CIK 0001778813 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,807

Underlying: Common Stock · 28,807 shares

Expires 2023-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 18:49 UTC Amendment
Scarborough AlveniaSVP Corp Communications & CBO
GrantPerformance Stock Option (Right to Buy) · Derivative 5,427 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017758 · doc4a.xml · derivative · entry 1

Scarborough Alvenia · CIK 0001826993 · SVP Corp Communications & CBO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,427

Underlying: Common Stock · 5,427 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 18:40 UTC Amendment
Lock JonathanSVP, Chief Development Officer
GrantPerformance Stock Option (Right to Buy) · Derivative 7,097 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017756 · doc4a.xml · derivative · entry 1

Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,097

Underlying: Common Stock · 7,097 shares

Expires 2023-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 18:37 UTC Amendment
Dignam DenisePresident, Adv Perf Materials
GrantPerformance Stock Option (Right to Buy · Derivative 13,777 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017754 · doc4a.xml · derivative · entry 1

Dignam Denise · CIK 0001848475 · President, Adv Perf Materials

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,777

Underlying: Common Stock · 13,777 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
March 01, 2023 Filed Mar 10, 2023 18:36 UTC Amendment
Bellezza AlishaPresident, Thermal Spec Solns
GrantPerformance Stock Option (Right to Buy · Derivative 13,777 $0.00 Strike: $38.32 $0.00
Disclosure

SEC source: 0001209191-23-017753 · doc4a.xml · derivative · entry 1

Bellezza Alisha · CIK 0001848483 · President, Thermal Spec Solns

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,777

Underlying: Common Stock · 13,777 shares

Expires 2033-03-01

F1 · derivative.exercise_price: Represents a 10 percent premium above the closing price of the Company common stock on the date of grant

F2 · shares: The original Form 4, filed on March 3, 2023, is amended by this Form 4 amendment solely to revise the number of performance stock options received by the reporting person.

F3 · derivative.exercise_date: These options are scheduled to vest in three equal annual installments beginning on March 1, 2024.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 13:10 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Tax withholdingCommon Stock 32,938 $34.35 $1,131,420.30
Disclosure

SEC source: 0001209191-23-009037 · doc4.xml · nonDerivative · entry 2

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,736.7361

F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 13:10 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
GrantCommon Stock 78,688 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009037 · doc4.xml · nonDerivative · entry 1

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,676.7361

F1 · shares: Vesting of performance share units (PSUs)

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 14:33 UTC
Newman MarkDirector · President and CEO
Tax withholdingCommon Stock 70,974 $34.35 $2,437,956.90
Disclosure

SEC source: 0001209191-23-009058 · doc4.xml · nonDerivative · entry 2

Newman Mark · CIK 0001524597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 221,250.8407

F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 14:33 UTC
Newman MarkDirector · President and CEO
GrantCommon Stock 147,540 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009058 · doc4.xml · nonDerivative · entry 1

Newman Mark · CIK 0001524597 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,224.8407

F1 · shares: Vesting of performance share units (PSUs)

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 13:11 UTC
Kelliher Susan M.SVP, People and Health Service
Tax withholdingCommon Stock 28,315 $34.35 $972,620.25
Disclosure

SEC source: 0001209191-23-009038 · doc4.xml · nonDerivative · entry 2

Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,174.8412

F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 13:11 UTC
Kelliher Susan M.SVP, People and Health Service
GrantCommon Stock 68,852 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009038 · doc4.xml · nonDerivative · entry 1

Kelliher Susan M. · CIK 0001568507 · SVP, People and Health Service

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,489.8412

F1 · shares: Vesting of performance share units (PSUs)

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 19:30 UTC
Lock JonathanSVP, Chief Development Officer
Tax withholdingCommon Stock 6,835 $34.35 $234,782.25
Disclosure

SEC source: 0001209191-23-009056 · doc4.xml · nonDerivative · entry 2

Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,028.4423

F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 19:30 UTC
Lock JonathanSVP, Chief Development Officer
GrantCommon Stock 20,654 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009056 · doc4.xml · nonDerivative · entry 1

Lock Jonathan · CIK 0001891480 · SVP, Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,863.4423

F1 · shares: Vesting of performance share units (PSUs).

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 19:22 UTC Tax withholdingCommon Stock 42,218 $34.35 $1,450,188.30
Disclosure

SEC source: 0001209191-23-009053 · doc4.xml · nonDerivative · entry 2

Ralhan Sameer · CIK 0001778813 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,710.0122

F3 · shares: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
February 10, 2023 Filed Feb 14, 2023 19:22 UTC GrantCommon Stock 98,360 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009053 · doc4.xml · nonDerivative · entry 1

Ralhan Sameer · CIK 0001778813 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 412,928.0122

F1 · shares: Vesting of performance share units (PSUs)

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
December 30, 2022 Filed Jan 4, 2023 14:40 UTC GrantStock Units · Derivative 408.2292 $30.62 $12,499.98
Disclosure

SEC source: 0001209191-23-000666 · doc4.xml · derivative · entry 3

Rogers Sandra Phillips · CIK 0001721471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,491.0155

Underlying: Common Stock · 408.2292 shares

Expires not disclosed

F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3 · derivative.exercise_date: Payable in 2025 per election under the Chemours deferred compensation plan for directors.

F3 · derivative.expiration_date: Payable in 2025 per election under the Chemours deferred compensation plan for directors.

Read SEC document
December 30, 2022 Filed Jan 4, 2023 19:39 UTC
Kane Erin NDirector
GrantStock Units · Derivative 816.4598 $30.62 $25,000.00
Disclosure

SEC source: 0001209191-23-000665 · doc4.xml · derivative · entry 2

Kane Erin N · CIK 0001684077 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,806.266

Underlying: Common Stock · 816.4598 shares

Expires not disclosed

F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3 · derivative.exercise_date: Payable upon separation of service.

F3 · derivative.expiration_date: Payable upon separation of service.

Read SEC document
November 07, 2022 Filed Nov 9, 2022 21:43 UTC
Dignam DenisePresident, Adv Perf Materials
Tax withholdingCommon Stock 2,248 $30.29 $68,091.92
Disclosure

SEC source: 0001209191-22-056231 · doc4.xml · nonDerivative · entry 1

Dignam Denise · CIK 0001848475 · President, Adv Perf Materials

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,995.6363

F1 · shares: Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.

F2 · balance_after: Includes directly owned shares, restricted stock units and dividend equivalent units.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 10:57 UTC GrantStock Units · Derivative 507.0994 $24.65 $12,500.00
Disclosure

SEC source: 0001209191-22-052056 · doc4.xml · derivative · entry 3

Rogers Sandra Phillips · CIK 0001721471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,071.3974

Underlying: Common Stock · 507.0994 shares

Expires not disclosed

F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3 · derivative.exercise_date: Payable in 2025 per election under the Chemours deferred compensation plan for directors.

F3 · derivative.expiration_date: Payable in 2025 per election under the Chemours deferred compensation plan for directors.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 13:36 UTC
Kane Erin NDirector
GrantStock Units · Derivative 1,014.1988 $24.65 $25,000.00
Disclosure

SEC source: 0001209191-22-052040 · doc4.xml · derivative · entry 2

Kane Erin N · CIK 0001684077 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,940.7576

Underlying: Common Stock · 1,014.1988 shares

Expires not disclosed

F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3 · derivative.exercise_date: Payable upon separation from service.

F3 · derivative.expiration_date: Payable upon separation from service.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 15:24 UTC GrantStock Units · Derivative 390.381 $32.02 $12,500.00
Disclosure

SEC source: 0001627223-22-000042 · primary_doc.xml · derivative · entry 3

Rogers Sandra Phillips · CIK 0001721471 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,547.1906

Underlying: Common Stock · 390.381 shares

Expires not disclosed

F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3 · derivative.exercise_date: Payable in 2025 per election under the Chemours deferred compensation plan for directors.

F3 · derivative.expiration_date: Payable in 2025 per election under the Chemours deferred compensation plan for directors.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 19:39 UTC
Kane Erin NDirector
GrantStock Units · Derivative 780.762 $32.02 $25,000.00
Disclosure

SEC source: 0001627223-22-000043 · primary_doc.xml · derivative · entry 2

Kane Erin N · CIK 0001684077 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890.3979

Underlying: Common Stock · 780.762 shares

Expires not disclosed

F2 · derivative.exercise_price: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.

F3 · derivative.exercise_date: Payable upon separation from service.

F3 · derivative.expiration_date: Payable upon separation from service.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 16:30 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Exercise / conversionStock Option (Right to Buy) · Derivative 17,830 $0.00 Strike: $21.96 $0.00
Disclosure

SEC source: 0001627223-22-000041 · primary_doc.xml · derivative · entry 6

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,830 shares

Expires 2029-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 16:30 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Exercise / conversionStock Option (Right to Buy) · Derivative 4,312 $0.00 Strike: $34.72 $0.00
Disclosure

SEC source: 0001627223-22-000041 · primary_doc.xml · derivative · entry 5

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,312 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option award was granted on March 1, 2017 with vesting in three equal annual installments beginning March 1, 2018.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 16:30 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
SaleCommon Stock 17,830 $43.59 $777,209.70
Disclosure

SEC source: 0001627223-22-000041 · primary_doc.xml · nonDerivative · entry 4

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,037.5941

F2 · price: Shares were sold in multiple transactions at prices ranging from $43.50 to $43.80.

F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 16:30 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Exercise / conversionCommon Stock 17,830 $21.96 $391,546.80
Disclosure

SEC source: 0001627223-22-000041 · primary_doc.xml · nonDerivative · entry 3

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,867.5941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 16:30 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
SaleCommon Stock 4,312 $43.59 $187,960.08
Disclosure

SEC source: 0001627223-22-000041 · primary_doc.xml · nonDerivative · entry 2

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,037.5941

F2 · price: Shares were sold in multiple transactions at prices ranging from $43.50 to $43.80.

F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units.

Read SEC document
June 07, 2022 Filed Jun 9, 2022 16:30 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Exercise / conversionCommon Stock 4,312 $34.72 $149,712.64
Disclosure

SEC source: 0001627223-22-000041 · primary_doc.xml · nonDerivative · entry 1

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,349.5941

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units.

Read SEC document
May 09, 2022 Filed May 9, 2022 22:21 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 20,175 $0.00 Strike: $5.40 $0.00
Disclosure

SEC source: 0001627223-22-000040 · primary_doc.xml · derivative · entry 6

Ralhan Sameer · CIK 0001778813 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,175 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017.

Read SEC document
May 09, 2022 Filed May 9, 2022 22:21 UTC SaleCommon Stock 20,175 $40.01 $807,201.75
Disclosure

SEC source: 0001627223-22-000040 · primary_doc.xml · nonDerivative · entry 4

Ralhan Sameer · CIK 0001778813 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,506.2256

F3 · price: Shares were sold in multiple transactions at prices ranging from $40.00 to $40.06.

F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units.

Read SEC document
May 09, 2022 Filed May 9, 2022 22:21 UTC Exercise / conversionCommon Stock 20,175 $5.40 $108,945.00
Disclosure

SEC source: 0001627223-22-000040 · primary_doc.xml · nonDerivative · entry 3

Ralhan Sameer · CIK 0001778813 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,681.2256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes directly owned shares, restricted stock units, and dividend equivalent units.

Read SEC document
May 06, 2022 Filed May 9, 2022 17:06 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Exercise / conversionStock Option (Right to Buy) · Derivative 12,270 $0.00 Strike: $24.01 $0.00
Disclosure

SEC source: 0001627223-22-000038 · primary_doc.xml · derivative · entry 9

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,539

Underlying: Common Stock · 12,270 shares

Expires 2031-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Option award was granted on March 1, 2021 with vesting in three equal annual installments beginning March 1, 2022.

Read SEC document
May 06, 2022 Filed May 9, 2022 17:06 UTC
Sparks Edwin CPresident, Titan Tech Chem Sol
Exercise / conversionStock Option (Right to Buy) · Derivative 27,997 $0.00 Strike: $14.43 $0.00
Disclosure

SEC source: 0001627223-22-000038 · primary_doc.xml · derivative · entry 8

Sparks Edwin C · CIK 0001735771 · President, Titan Tech Chem Sol

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,520

Underlying: Common Stock · 27,997 shares

Expires 2030-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.